A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma C Bertolotto, F Lesueur, S Giuliano, T Strub, M De Lichy, K Bille, P Dessen, ... Nature 480 (7375), 94-98, 2011 | 599 | 2011 |
Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma T Strub, S Giuliano, T Ye, C Bonet, C Keime, D Kobi, S Le Gras, ... Oncogene 30 (20), 2319-2332, 2011 | 287 | 2011 |
Histone variant H2A. Z. 2 mediates proliferation and drug sensitivity of malignant melanoma C Vardabasso, A Gaspar-Maia, D Hasson, S Pünzeler, D Valle-Garcia, ... Molecular cell 59 (1), 75-88, 2015 | 199 | 2015 |
Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells P Laurette, T Strub, D Koludrovic, C Keime, S Le Gras, H Seberg, ... Elife 4, e06857, 2015 | 192 | 2015 |
SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling T Strub, FG Ghiraldini, S Carcamo, M Li, A Wroblewska, R Singh, ... Nature communications 9 (1), 3440, 2018 | 87 | 2018 |
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease C Pandiani, T Strub, N Nottet, Y Cheli, G Gambi, K Bille, C Husser, ... Cell Death & Differentiation 28 (6), 1990-2000, 2021 | 67 | 2021 |
The “ART” of epigenetics in melanoma: from histone “alterations, to resistance and therapies” T Strub, R Ballotti, C Bertolotto Theranostics 10 (4), 1777, 2020 | 55 | 2020 |
Tuning transcription factor availability through acetylation-mediated genomic redistribution P Louphrasitthiphol, R Siddaway, A Loffreda, V Pogenberg, ... Molecular cell 79 (3), 472-487. e10, 2020 | 50 | 2020 |
Chromatin-remodelling complex NURF is essential for differentiation of adult melanocyte stem cells D Koludrovic, P Laurette, T Strub, C Keime, M Le Coz, S Coassolo, ... PLoS genetics 11 (10), e1005555, 2015 | 46 | 2015 |
MITF in normal melanocytes, cutaneous and uveal melanoma: a delicate balance MC Gelmi, LE Houtzagers, T Strub, I Krossa, MJ Jager International journal of molecular sciences 23 (11), 6001, 2022 | 41 | 2022 |
Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression C Bonet, F Luciani, JF Ottavi, J Leclerc, FM Jouenne, M Boncompagni, ... JNCI: Journal of the National Cancer Institute 109 (8), djw340, 2017 | 35 | 2017 |
BRCA1 is a new MITF target gene. L Beuret, M Ohanna, T Strub, M Allegra, I Davidson, C Bertolotto, ... Pigment Cell & melanoma research 24 (4), 2011 | 23 | 2011 |
Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology T Strub, A Martel, S Nahon-Esteve, S Baillif, R Ballotti, C Bertolotto Progress in Retinal and Eye Research 85, 100968, 2021 | 17 | 2021 |
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity Y Cheli, MK Tulic, N El Hachem, N Nottet, A Jacquel, M Gesson, T Strub, ... Molecular cancer 20, 1-5, 2021 | 13 | 2021 |
Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells L Bellini, T Strub, N Habel, C Pandiani, S Marchetti, A Martel, S Baillif, ... Cell death discovery 6 (1), 22, 2020 | 13 | 2020 |
Correction: Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma C Bertolotto, F Lesueur, S Giuliano, T Strub, M de Lichy, K Bille, P Dessen, ... Nature 531 (7592), 126-126, 2016 | 10 | 2016 |
Recent advances in understanding the role of HES6 in cancers I Krossa, T Strub, A Martel, S Nahon-Esteve, S Lassalle, P Hofman, ... Theranostics 12 (9), 4374, 2022 | 8 | 2022 |
A POU3F2-MITF-SHC4 axis in phenotype switching of melanoma cells T Strub, D Kobi, D Koludrovic, I Davidson Research on Melanoma—A Glimpse into Current Directions and Future Trends 10 …, 2011 | 5 | 2011 |
Resolution of tridimensional instationary Maxwell's equations on massively multicore architecture T Strub HAL 2015, 2015 | 4 | 2015 |
LKB1‐SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition S Proteau, I Krossa, C Husser, M Guéguinou, F Sella, K Bille, M Irondelle, ... EMBO Molecular Medicine 15 (12), e17719, 2023 | 2 | 2023 |